Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread S Ambike, CC Cheng, M Feuerherd, S Velkov, D Baldassi, SQ Afridi, ... Nucleic Acids Research 50 (1), 333-349, 2022 | 50 | 2022 |
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes D Baldassi, S Ambike, M Feuerherd, CC Cheng, DJ Peeler, DP Feldmann, ... Journal of Controlled Release 345, 661-674, 2022 | 28 | 2022 |
Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target S Ambike, C Cheng, S Afridi, M Feuerherd, P Hagen, V Grass, O Merkel, ... | 6 | 2020 |
Partial pol Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, India SS Ambike, MR Thakar, AA Patil, RR Gangakhedkar, SN Kurle AIDS Research and Human Retroviruses 35 (5), 505-508, 2019 | 4 | 2019 |
Unravelling the role of hepatocytes in hepatitis B virus specific immunotolerance M Zehentmeier, S Ambike, U Protzer, T Michler Zeitschrift für Gastroenterologie 60 (01), P 5.33, 2022 | 1 | 2022 |
RECOMBINANT MOSAIC HBV CAPSID PARTICLES FOSTER ADAPTIVE IMMUNITY AGAINST THE MOST PREVALENT HBV GENOTYPES BY THERAPEUTIC VACCINATION S Ambike, J Sacherl, A Seidler, A Geerlof, A Kosinska, S Schreiber, ... HEPATOLOGY 78, S586-S586, 2023 | | 2023 |
SARS-CoV-2 productively infects human hepatocytes and induces cell death CC Cheng, C Ko, S Ambike, J Sacherl, S Velkov, BH Liao, R Bester, ... | | 2023 |
ORF1 REGION of SARS-C V-2 GENOMIC RNA AS A PROMISING TARGET for siRNA-BASED THERAPY S Ambike, CC Cheng, M Feuerherd, D Baldassi, S Velkov, G Burgstaller, ... Topics in Antiviral Medicine, 67-67, 2022 | | 2022 |
Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target (preprint) S Ambike, CC Cheng, S Afridi, M Feuerherd, P Hagen, V Grass, O Merkel, ... | | 2020 |